CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 525 of 870
Non-Antibody Products
Page 525 of 870
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| Moclobemide | An analytical reference standard categorized as an antidepressant; intende… | 1 mg | 24361-1 | More Info |
| Moclobemide | An analytical reference standard categorized as an antidepressant; intende… | 5 mg | 24361-5 | More Info |
| Moclobemide-d4 | An internal standard for the quantification of moclobemide by GC- or LC-MS | 1 mg | 34247-1 | More Info |
| Moclobemide-d4 | An internal standard for the quantification of moclobemide by GC- or LC-MS | 10 mg | 34247-10 | More Info |
| Moclobemide-d4 | An internal standard for the quantification of moclobemide by GC- or LC-MS | 25 mg | 34247-25 | More Info |
| Moclobemide-d4 | An internal standard for the quantification of moclobemide by GC- or LC-MS | 5 mg | 34247-5 | More Info |
| Modafinil | A wake-promoting inhibitor of the dopamine transporter (IC50 = 3 µM;… | 10 mg | 15417-10 | More Info |
| Modafinil | A wake-promoting inhibitor of the dopamine transporter (IC50 = 3 µM;… | 25 mg | 15417-25 | More Info |
| Modafinil | A wake-promoting inhibitor of the dopamine transporter (IC50 = 3 µM;… | 5 mg | 15417-5 | More Info |
| Modafinil | A wake-promoting inhibitor of the dopamine transporter (IC50 = 3 µM;… | 50 mg | 15417-50 | More Info |
| Moenomycin Complex | A mixture of moenomycins A, A12, C1, C3 and C4, which are antibiotics isol… | 25 mg | 15506-25 | More Info |
| Moenomycin Complex | A mixture of moenomycins A, A12, C1, C3 and C4, which are antibiotics isol… | 5 mg | 15506-5 | More Info |
| Moexiprilat | An ACE inhibitor and active metabolite of the prodrug moexipril (IC50 = 2.… | 1 mg | 38047-1 | More Info |
| Moexiprilat | An ACE inhibitor and active metabolite of the prodrug moexipril (IC50 = 2.… | 10 mg | 38047-10 | More Info |
| Moexiprilat | An ACE inhibitor and active metabolite of the prodrug moexipril (IC50 = 2.… | 5 mg | 38047-5 | More Info |
| Moexipril-d5 | An internal standard for the quantification of moexipril by GC- or LC-MS | 1 mg | 33814-1 | More Info |
| Moexipril-d5 | An internal standard for the quantification of moexipril by GC- or LC-MS | 10 mg | 33814-10 | More Info |
| Moexipril-d5 | An internal standard for the quantification of moexipril by GC- or LC-MS | 5 mg | 33814-5 | More Info |
| Moexipril (hydrochloride) | A prodrug form of moexiprilat; inhibits ACE in a cell-free assay (IC50 = 2… | 10 mg | 21255-10 | More Info |
| Moexipril (hydrochloride) | A prodrug form of moexiprilat; inhibits ACE in a cell-free assay (IC50 = 2… | 100 mg | 21255-100 | More Info |
| Moexipril (hydrochloride) | A prodrug form of moexiprilat; inhibits ACE in a cell-free assay (IC50 = 2… | 25 mg | 21255-25 | More Info |
| Moexipril (hydrochloride) | A prodrug form of moexiprilat; inhibits ACE in a cell-free assay (IC50 = 2… | 50 mg | 21255-50 | More Info |
| Mofegiline (hydrochloride) | An inhibitor of MAO-B (IC50 = 3.6 nM for the rat brain mitochondrial enzym… | 25 mg | 35010-25 | More Info |
| Mofegiline (hydrochloride) | An inhibitor of MAO-B (IC50 = 3.6 nM for the rat brain mitochondrial enzym… | 50 mg | 35010-50 | More Info |
| Mofezolac | A COX-1 inhibitor (IC50 = 14 nM); selective for COX-1 over COX-2 (IC50 = 4… | 10 mg | 34102-10 | More Info |
| Mofezolac | A COX-1 inhibitor (IC50 = 14 nM); selective for COX-1 over COX-2 (IC50 = 4… | 25 mg | 34102-25 | More Info |
| Mofezolac | A COX-1 inhibitor (IC50 = 14 nM); selective for COX-1 over COX-2 (IC50 = 4… | 5 mg | 34102-5 | More Info |
| Mofezolac | A COX-1 inhibitor (IC50 = 14 nM); selective for COX-1 over COX-2 (IC50 = 4… | 50 mg | 34102-50 | More Info |
| MOG (35-55) (mouse, rat) (trifluoroacetate salt) | An MOG antigen peptide; induces demyelination of the spinal cord, degenera… | 1 mg | 35644-1 | More Info |
| MOG (35-55) (mouse, rat) (trifluoroacetate salt) | An MOG antigen peptide; induces demyelination of the spinal cord, degenera… | 10 mg | 35644-10 | More Info |
| MOG (35-55) (mouse, rat) (trifluoroacetate salt) | An MOG antigen peptide; induces demyelination of the spinal cord, degenera… | 5 mg | 35644-5 | More Info |
| MOG (35-55) (mouse, rat) (trifluoroacetate salt) | An MOG antigen peptide; induces demyelination of the spinal cord, degenera… | 500 µg | 35644-500 | More Info |
| MOG Peptide (human, bovine) (acetate) | An endogenous myelin sheath peptide; reduces cortical and striatal infarct… | 1 mg | 36906-1 | More Info |
| MOG Peptide (human, bovine) (acetate) | An endogenous myelin sheath peptide; reduces cortical and striatal infarct… | 10 mg | 36906-10 | More Info |
| MOG Peptide (human, bovine) (acetate) | An endogenous myelin sheath peptide; reduces cortical and striatal infarct… | 5 mg | 36906-5 | More Info |
| MOG Peptide (human, bovine) (acetate) | An endogenous myelin sheath peptide; reduces cortical and striatal infarct… | 500 µg | 36906-500 | More Info |
| Mogrol | An aglycone with diverse biological activities; inhibits the proliferation… | 10 mg | 39253-10 | More Info |
| Mogrol | An aglycone with diverse biological activities; inhibits the proliferation… | 25 mg | 39253-25 | More Info |
| Mogrol | An aglycone with diverse biological activities; inhibits the proliferation… | 5 mg | 39253-5 | More Info |
| Mogrol | An aglycone with diverse biological activities; inhibits the proliferation… | 50 mg | 39253-50 | More Info |
| Mogroside IIIE | A cucurbitane glycoside with anti-inflammatory activity; inhibits LPS-indu… | 1 mg | 39286-1 | More Info |
| Mogroside IIIE | A cucurbitane glycoside with anti-inflammatory activity; inhibits LPS-indu… | 10 mg | 39286-10 | More Info |
| Mogroside IIIE | A cucurbitane glycoside with anti-inflammatory activity; inhibits LPS-indu… | 25 mg | 39286-25 | More Info |
| Mogroside IIIE | A cucurbitane glycoside with anti-inflammatory activity; inhibits LPS-indu… | 5 mg | 39286-5 | More Info |
| Mogroside V | A natural cucurbitane glycoside that is used as a low calorie sweetener | 1 mg | 19853-1 | More Info |
| Mogroside V | A natural cucurbitane glycoside that is used as a low calorie sweetener | 10 mg | 19853-10 | More Info |
| Mogroside V | A natural cucurbitane glycoside that is used as a low calorie sweetener | 25 mg | 19853-25 | More Info |
| Mogroside V | A natural cucurbitane glycoside that is used as a low calorie sweetener | 5 mg | 19853-5 | More Info |
| Moguisteine | A peripherally acting antitussive agent; inhibits the citric acid-induced… | 1 g | 30362-1 | More Info |
| Moguisteine | A peripherally acting antitussive agent; inhibits the citric acid-induced… | 100 mg | 30362-100 | More Info |
| Moguisteine | A peripherally acting antitussive agent; inhibits the citric acid-induced… | 250 mg | 30362-250 | More Info |
| Moguisteine | A peripherally acting antitussive agent; inhibits the citric acid-induced… | 5 g | 30362-5 | More Info |
| Molindone (hydrochloride) | A dopamine receptor antagonist; selectively inhibits radioligand binding t… | 1 g | 23841-1 | More Info |
| Molindone (hydrochloride) | A dopamine receptor antagonist; selectively inhibits radioligand binding t… | 5 g | 23841-5 | More Info |
| Molindone (hydrochloride) | A dopamine receptor antagonist; selectively inhibits radioligand binding t… | 500 mg | 23841-500 | More Info |
| Molnupiravir | A prodrug form of EIDD-1931; reduces body weight loss, lung hemorrhage, an… | 1 mg | 29586-1 | More Info |
| Molnupiravir | A prodrug form of EIDD-1931; reduces body weight loss, lung hemorrhage, an… | 10 mg | 29586-10 | More Info |
| Molnupiravir | A prodrug form of EIDD-1931; reduces body weight loss, lung hemorrhage, an… | 25 mg | 29586-25 | More Info |
| Molnupiravir | A prodrug form of EIDD-1931; reduces body weight loss, lung hemorrhage, an… | 5 mg | 29586-5 | More Info |
| Molsidomine | Molsidomine is a NO-releasing prodrug. Liver esterases convert molsidomine… | 100 mg | 82200-100 | More Info |
| Molsidomine | Molsidomine is a NO-releasing prodrug. Liver esterases convert molsidomine… | 1000 mg | 82200-1 | More Info |
| Molsidomine | Molsidomine is a NO-releasing prodrug. Liver esterases convert molsidomine… | 500 mg | 82200-500 | More Info |
| Molsidomine | Molsidomine is a NO-releasing prodrug. Liver esterases convert molsidomine… | 5000 mg | 82200-5 | More Info |
| Mometasone | A synthetic glucocorticoid; reduces pulmonary edema and neutrophil infiltr… | 1 mg | 31702-1 | More Info |
| Mometasone | A synthetic glucocorticoid; reduces pulmonary edema and neutrophil infiltr… | 500 µg | 31702-500 | More Info |
| Mometasone Furoate | A prodrug form of glucocorticoid mometasone; reduces frequency of sneezing… | 100 mg | 21365-100 | More Info |
| Mometasone Furoate | A prodrug form of glucocorticoid mometasone; reduces frequency of sneezing… | 25 mg | 21365-25 | More Info |
| Mometasone Furoate | A prodrug form of glucocorticoid mometasone; reduces frequency of sneezing… | 250 mg | 21365-250 | More Info |
| Mometasone Furoate | A prodrug form of glucocorticoid mometasone; reduces frequency of sneezing… | 50 mg | 21365-50 | More Info |
| Mometasone Furoate-d3 | An internal standard for the quantification of mometasone furoate by GC- o… | 1 mg | 33470-1 | More Info |
| Mometasone Furoate-d3 | An internal standard for the quantification of mometasone furoate by GC- o… | 5 mg | 33470-5 | More Info |
| Mometasone Furoate-d3 | An internal standard for the quantification of mometasone furoate by GC- o… | 500 µg | 33470-500 | More Info |
| MOMIPP | An inhibitor of PIKfyve (IC50 = 5.05 nM); selectively binds to PIKfyve ove… | 100 mg | 39671-100 | More Info |
| MOMIPP | An inhibitor of PIKfyve (IC50 = 5.05 nM); selectively binds to PIKfyve ove… | 250 mg | 39671-250 | More Info |
| MOMIPP | An inhibitor of PIKfyve (IC50 = 5.05 nM); selectively binds to PIKfyve ove… | 50 mg | 39671-50 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile